Regeneron Pharmaceuticals Inc. and Sanofi SA said their arthritis drug Kevzara failed to help Covid-19 patients recover in a U.S. clinical trial.
The failure clouds a class of drugs being studied as potential treatments for Covid-19 patients who experience an abnormal immune response known as “cytokine storm,” which researchers and doctors suspect contributes to the deaths of some patients.
Real Life. Real News. Real Voices
Help us tell more of the stories that matterBecome a founding member
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe